Saudi Arabia-Based Metafare Secures $1M to Scale VR and AI-Driven Wellness
A new wave of immersive healthtech innovation is gaining traction in the Middle East, as Saudi Arabia-based startup Metafare raises […]
News
AIMS Director, Dr. M. Srinivas Appointed as NITI Aayog Member, Succeeds Dr. V. K. Paul
The Government of India has appointed Dr. M. Srinivas, Director of All India Institute of Medical Sciences, as a Member […]
$100 Million Life Sciences Campus to Come Up in Hyderabad, Boosting Genome Valley’s Global Standing
Hyderabad is set to strengthen its position as India’s life sciences hub with a major new investment, as Rx Propellant […]
Botanic Healthcare Appoints Kamalakar V. Arcot as Group CEO to Accelerate Global Growth
To strengthen international footprint, Botanic Healthcare has appointed Kamalakar V. Arcot as its Group Chief Executive Officer. The appointment comes […]
Yatharth Group of Hospitals Launches Delhi NCR’s first dedicated Advanced Brain Stimulation Centre in Faridabad
Faridabad: Yatharth Super Speciality Hospital has launched Delhi NCR’s first dedicated Advanced Brain Stimulation Centre. The initiative underscores the growing […]
Healthians Founder Deepak Sahni Announces ‘Un:Bloc’; Aimed at Solving Systemic Challenges at Scale
Serial entrepreneur, angel investor, and Founder of Healthians, Deepak Sahni has announced the launch of his new venture, Un:Bloc, marking […]
Biogen to Acquire Apellis Pharmaceuticals in $5.6 Billion Deal
Biogen has announced plans to acquire Apellis Pharmaceuticals in a deal valued at $5.6 billion to expand its portfolio in […]
US FDA Warns of Liver Injury Cases Linked to Amgen’s Rare Disease Drug
The US Food and Drug Administration (FDA) has reported cases of liver injury in patients treated with Amgen’s drug Tavneos […]
US FDA Expected to Lift Restrictions on Certain Peptides
The US Food and Drug Administration (FDA) is expected to lift restrictions on certain injectable peptides, which would allow compounding […]
Lilly’s Eczema Drug Shows Durable Long-Term Response in Late-Stage Study
Eli Lilly said its eczema drug lebrikizumab (Ebglyss) showed durable long-term response in a late-stage study, with data highlighting sustained […]
EU Regulator Backs Sanofi’s Injectable Version of Blood Cancer Drug
Sanofi has received a positive recommendation from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) […]
Biocon Appoints Shreehas P. Tambe as CEO & MD; Siddharth Mittal Steps Down
Biocon Limited has appointed Shreehas P. Tambe as its Chief Executive Officer and Managing Director, following the resignation of Siddharth […]
Corcept Therapeutics Receives US FDA Approval for Ovarian Cancer Drug
The US Food and Drug Administration (FDA) has approved Corcept Therapeutics’ relacorilant for the treatment of platinum-resistant epithelial ovarian cancer. […]
